AstraZeneca Taken to Court Over “Defective” Covid Jab in Landmark Legal Case
The Oxford-AstraZeneca COVID-19 vaccine has been branded “defective” in a multi-million pound landmark legal action that will suggest claims over its efficacy were “vastly overstated”.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
